Xiangyu Che

department of urology

H指数:20

被引数:1,271

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Letter to editor: "Radiologic imaging aids management of high-risk cutaneous squamous cell carcinoma: A retrospective cohort study"

致编辑函：“放射学影像有助于高危皮肤鳞状细胞癌的管理：一项回顾性队列研究”

Journal of the American Academy of Dermatology

IF11.8

2025-12-080

PRE

Letter to Editor: Respiratory symptoms associated with a new lobe-based bronchial scoring system in an urban Chinese low-dose CT screening population

致编辑：与一种基于肺叶的支气管评分系统相关的呼吸系统症状在中国城市低剂量CT筛查人群中的研究

European Radiology

IF4.7

2025-10-170

PRE

Covered Metal Ureteral Stents in the Maintenance Treatment of Refractory Ureteral Stricture: A Prospective, Multi-Center, and Large-Scale Cohort Study with 3-Year Outcomes

金属覆膜输尿管支架在难治性输尿管狭窄维持治疗中的应用：一项前瞻性、多中心、大样本队列研究及3年随访结果

JOURNAL OF ENDOUROLOGY

IF2.8

2025-09-010

PRE

Letter to the Editor: Contrast media and radiation dose optimization with task-based automatic keV selection: a proof-of-concept study with photon-counting detector CT

致编辑函：基于任务目标的自动kVp选择对比剂与辐射剂量优化：一项基于光子计数探测器CT的概念验证研究

European Radiology

IF4.7

2025-08-010

PRE

A Novel Approach for Bladder Cancer Treatment Nanoparticles as a Drug Delivery System

膀胱癌治疗纳米颗粒作为药物递送系统的新方法

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2024-12-010

OAAI

Adeno-associated virus therapies: Pioneering solutions for human genetic diseases

CYTOKINE & GROWTH FACTOR REVIEWS

IF11.8

2024-12-011

OAAI

Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective

VACCINES

IF3.4

2024-08-227

OAAI

Frontiers in sarcopenia: Advancements in diagnostics, molecular mechanisms, and therapeutic strategies

肌肉减少症的前沿: 诊断，分子机制和治疗策略的进展

MOLECULAR ASPECTS OF MEDICINE

IF10.3

2024-06-017

OAAI

Evaluating the Role of Neddylation Modifications in Kidney Renal Clear Cell Carcinoma: An Integrated Approach Using Bioinformatics, MLN4924 Dosing Experiments, and RNA Sequencing

评估Neddylation修饰在肾脏肾透明细胞癌中的作用: 使用生物信息学，MLN4924剂量实验和RNA测序的综合方法

PHARMACEUTICALS

IF4.8

2024-05-153

OAAI

Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways

BIOMARKER RESEARCH

IF11.5

2024-01-088

OAAI

RETRACTION: Isoquercitrin inhibits bladder cancer progression in vitro and in vivo by regulating the PI3K/Akt and PKC signaling pathways (Retraction of Vol 36, Pg 165, 2016)

ONCOLOGY REPORTS

IF3.9

2023-12-180

PRE

Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer

PHARMACEUTICALS

IF4.8

2023-09-2927

OAAI

Lipid metabolism in ferroptosis and ferroptosis-based cancer therapy

铁死亡和基于铁死亡的癌症治疗中的脂质代谢

FRONTIERS IN ONCOLOGY

IF3.3

2022-08-0124

OAAI

Application of Regulatory Cell Death in Cancer: Based on Targeted Therapy and Immunotherapy

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-03-1029

OAAI

Angiogenesis Pathway in Kidney Renal Clear Cell Carcinoma and Its Prognostic Value for Cancer Risk Prediction

肾透明细胞癌血管生成途径及其对癌症风险预测的预后价值

FRONTIERS IN MEDICINE

IF3

2021-10-287

OAAI

A new prognostic risk model based on autophagy-related genes in kidney renal clear cell carcinoma

BIOENGINEERED

IF4.2

2021-10-129

OAAI

The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC

肾透明细胞癌的独特性: ccRCC糖脂代谢过程及异常总结

FRONTIERS IN ONCOLOGY

IF3.3

2021-09-1549

OAAI

Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N6-Methyladenosine RNA Methylation Regulators

JOURNAL OF IMMUNOLOGY RESEARCH

IF3.6

2021-02-1210

OAAI

Taurine inhibits neuron apoptosis in hippocampus of diabetic rats and high glucose exposed HT-22 cells via the NGF-Akt/Bad pathway

AMINO ACIDS

IF2.4

2019-12-2420

PREAI

Oridonin enhances the cytotoxicity of 5-FU in renal carcinoma cells by inducting necroptotic death

冬凌草甲素通过诱导坏死性死亡增强5-FU在肾癌细胞中的细胞毒性

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2018-10-0141

PREAI

Xiangyu Che

个人简介

教育背景

工作经历

荣誉奖项

研究方向